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Cellular senescence is a potent tumor suppressor mechanism but also contributes to aging and aging-related dis-
eases. Senescence is characterized by a stable cell cycle arrest and a complex proinflammatory secretome, termed the
senescence-associated secretory phenotype (SASP). We recently discovered that cytoplasmic chromatin fragments
(CCFs), extruded from the nucleus of senescent cells, trigger the SASP through activation of the innate immunity
cytosolic DNA sensing cGAS–STING pathway. However, the upstream signaling events that instigate CCF for-
mation remain unknown. Here, we show that dysfunctional mitochondria, linked to down-regulation of nuclear-
encoded mitochondrial oxidative phosphorylation genes, trigger a ROS–JNK retrograde signaling pathway that
drives CCF formation and hence the SASP. JNK links to 53BP1, a nuclear protein that negatively regulates DNA
double-strand break (DSB) end resection and CCF formation. Importantly, we show that low-dose HDAC inhibitors
restore expression of most nuclear-encodedmitochondrial oxidative phosphorylation genes, improvemitochondrial
function, and suppress CCFs and the SASP in senescent cells. In mouse models, HDAC inhibitors also suppress
oxidative stress, CCF, inflammation, and tissue damage caused by senescence-inducing irradiation and/or acet-
aminophen-induced mitochondria dysfunction. Overall, our findings outline an extended mitochondria-to-nucleus
retrograde signaling pathway that initiates formation of CCF during senescence and is a potential target for drug-
based interventions to inhibit the proaging SASP.
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Cellular senescence is a stable cell cycle arrest that can be
induced by replicative exhaustion and other stresses, such
as DNA damage and aberrant oncogenic activation. By
preventing the growth of oncogene-expressing, damaged,
or stressed cells, senescence is a potent barrier to tumori-
genesis (Herranz and Gil 2018).
Senescent cells display important and unique proper-
ties, including changes in morphology and metabolism,
subcellular organelles, and profound chromatin remodel-
ing. In addition, senescent cells secrete a complex
combination of proinflammatory cytokines, chemokines,
growth factors, and proteases, termed the senescence-as-
sociated secretory phenotype (SASP) (Coppé et al. 2008;
Rodier and Campisi 2011). The SASP acts in a cell-auton-
omous manner to reinforce the senescent state (Acosta
et al. 2008; Kuilman et al. 2008) but also communicates
with and alters the microenvironment (Nelson et al.
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2012; Acosta et al. 2013). SASP factors can contribute to
tumor suppression by promoting immune-mediated clear-
ance of damaged or premalignant cells (Kang et al. 2011).
However, the SASP can also be responsible for persistent
chronic inflammation and tissue damage. Chronic inflam-
mation can cause or greatly accelerate degenerative and
neoplastic diseases associated with aging, including can-
cer (Baker et al. 2011; Yoshimoto et al. 2013; van Deursen
2014; Milanovic et al. 2018). Consequently, there is grow-
ing interest in developing therapeutic agents to suppress
the deleterious effects of senescent cells. There is current-
ly much effort devoted to developing compounds (termed
senolytics) that selectively kill senescent cells (Kirkland
et al. 2017). Given the role of the SASP in mediating the
detrimental effects of senescent cells, SASP inhibition
(by so-called senostatics or senomorphics) can be an alter-
native to senolytics to promote healthy aging (Nie-
dernhofer and Robbins 2018; Short et al. 2019). Hence, it
is important to better understand how the SASP is regulat-
ed because its modulation may be a potential avenue to
combat the proaging effects of senescent cells.
We previously showed that senescent cells shed frag-
ments of nuclear chromatin into the cytoplasm, termed
cytoplasmic chromatin fragments (CCFs), via a nucleus-
to-cytoplasmic blebbing process (Ivanov et al. 2013).
CCFs are positive for the DNA damage marker γH2AX
but lack its usual partner, 53BP1. They are enriched
in heterochromatin markers including H3K9me3 and
H3K27me3 but devoid of certain euchromatin markers,
such as H3K9ac (Ivanov et al. 2013). Importantly, we dis-
covered that CCF formation depends on a nuclear lamin
B1-LC3 interaction (Dou et al. 2015) and that these frag-
ments initiate the SASP program during senescence (Dou
et al. 2017;Glücket al. 2017;Yang et al. 2017). Specifically,
CCFs are recognized by the cytosolic DNA sensor cGAS
that produces the second messenger cyclic GMP-AMP
(cGAMP), which binds and activates the adaptor protein
STING. The cGAS–STING pathway leads to activation
ofNFκB signaling that turns on transcription of proinflam-
matory genes (Douet al. 2017;Glücket al. 2017;Yang et al.
2017). However, the initiating signals of CCF formation
are unknown.
Senescent cells are metabolically active but accumu-
late dysfunctional mitochondria resulting in increased
mitochondrial mass, increased oxygen consumption, de-
creased efficiency of oxidative phosphorylation, decreased
membrane potential, and increased levels of reactive
oxygen species (ROS) (Passos et al. 2007; Moiseeva et al.
2009; Kaplon et al. 2013; Korolchuk et al. 2017). Mito-
chondria have been reported to contribute to SASP induc-
tion in senescence (Correia-Melo et al. 2016). However,
the underlying mechanism and whether dysfunctional
mitochondria are functionally connected to the SASP
through CCFs is unclear. Here, we examined the role of
mitochondria in mediating CCF formation in senescence
and discovered a mitochondria-to-nucleus retrograde sig-
naling event that triggers CCFs and the SASP. We show
that this pathway is a druggable target to dampen expres-
sion of proaging inflammatory genes and ameliorate fea-
tures of inflammatory disease.
Results
Mitochondria are required for CCF formation
in senescent cells
We initiated our study by investigating the potential con-
nection of mitochondria and CCFs. As the first step, we
analyzed the RNA-seq data from IMR90 primary human
fibroblasts induced to senesce by ionizing irradiation
(IR). This analysis showed that expression of nuclear-en-
coded mitochondrial oxidative phosphorylation genes be-
longing to the complexes I, II, III, IV, and V are generally
reduced (Fig. 1A). Gene set enrichment analysis (GSEA)
confirmed significant down-regulation of nuclear-encod-
ed mitochondrial genes in senescent (IR) cells (Supple-
mental Fig. S1A). This was also confirmed by qPCR of
gene transcripts, showing that the steady-state mRNA
levels of NDUFA10, NDUFA12, NDUFC2, and NDUFS8
were significantly reduced in irradiated senescent cells
(Supplemental Fig. S1B). In line with this, senescent cells
accumulated mitochondria that showed decreased mito-
chondrial membrane potential and increased mitochon-
drial ROS and increased levels of mitochondrial SOD2
mRNA, product of a ROS-responsive gene (Fig. 1B–D;
Kops et al. 2002). Together, these data show that senes-
cent cells down-regulate expression of nuclear-encoded
oxidative phosphorylation genes, accompanied bymarked
mitochondria dysfunction and ROS production.
We then tested whether dysfunctional mitochondria
are connected to CCFs, because mitochondria and CCFs
have both been reported to drive the SASP (Correia-Melo
et al. 2016; Dou et al. 2017; Glück et al. 2017; Yang
et al. 2017). We used a Parkin-mediated mitophagy model
to remove mitochondria in senescent cells (Correia-Melo
et al. 2016). Briefly, IMR90 primary human fibroblasts
were stably transduced with control or a Parkin-YFP fu-
sion protein (hereafter referred to as Parkin) followed by
induction of senescence by IR. Two days after irradiation,
cells were treated with the mitochondrial uncoupler car-
bonyl cyanide m-chlorophenylhydrazone (CCCP) to in-
duce mitochondrial depolarization and Parkin-mediated
mitophagy. Cells were harvested 10 d after irradiation
(Fig. 1E). We confirmed that expression of mitochondrial
proteins was dramatically reduced in Parkin CCCP-
treated senescent cells but not in control CCCP-treated
senescent cells, as assessed by immunoblotting (Fig. 1F).
Clearance ofmitochondriawas also confirmed by staining
for mitochondrial Tom20 (Fig. 1G). Absence of mitochon-
dria did not impair the senescence growth arrest, as shown
by loss of phosphorylated pRB (ph-Rb) and cyclinA and in-
duction of p21 (Supplemental Fig. S1C). Consistent with
our previous studies (Ivanov et al. 2013; Dou et al. 2017),
CCFs were detected in ∼30%–50% of control senescent
cells by stainingwithDAPI and γH2AX (Fig. 1H). Striking-
ly, senescent cells lacking mitochondria showed strong
suppression of CCFs (Fig. 1H; Supplemental Fig. S1D),
suggesting that mitochondria are necessary for CCF
formation.
Because CCF generation is a pivotal event triggering the
SASP (Dou et al. 2017; Glück et al. 2017; Yang et al. 2017),
we next examined the effects ofmitochondria elimination
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Figure 1. Mitochondria are required for formation of CCFs. (A) Heat map of RNA-seq analysis of nuclear-encoded mitochondrial genes
belonging to complexes I, II (CII), III (CIII), IV (CIV), and V (CV) in proliferating (Prolif) and senescent (IR) IMR90 cells 10 d after IR, from
n= 3 independent experiments. The color intensity represents the log2 fold change, where red indicates highly and blue lowly expressed.
(B) Ten days after IR, proliferating (Prolif) and senescent (IR) IMR90 cells were incubated with TMRE (100 nM) and Mitotracker Green
(MTG; 100nM) followedby flowcytometric analysis. The ratio ofTMREandMTGfluorescence intensitywas used to representmitochon-
drial membrane potential (MMP). (C ) Mitochondrial reactive oxygen species (mROS) were measured by flow cytometry using MitoSOX
(5 μM) in proliferating (Prolif) and senescent (IR) IMR90 cells 10 d after IR. For raw data, see Supplemental Figures S6 and S7. (D) Expression
of anti-ROS gene SOD2 was determined by RT-qPCR in proliferating (Prolif) and senescent (IR) IMR90 cells 10 d after IR. Data shown
in B–D are mean±SEM of n= 3 independent experiments. P-value was calculated by unpaired two-tailed Student’s t-test. (∗∗∗) P <0.001;
(∗) P <0.05. (E) Scheme summarizing the experimental design of Parkin-directed mitophagy experiments in F–K. (F ) The expression of
mitochondrial proteins from the different mitochondrial complexes NDUFB8 (complex I), SDHA (complex II), and UQCR2 (complex III)
and for the mitochondrial outer membrane marker Tom20 were analyzed by immunoblotting in senescent (IR) control (C) and Parkin
(P)-expressing IMR90 cells treated with or without CCCP. (G) Representative fluorescent images of Tom20 staining in senescent (IR) Par-
kin-expressing cells treated with or without CCCP. Scale bar, 20 μm. (H) Representative confocal immunofluorescence images of prolifer-
ating (Prolif) and senescent (IR) Parkin-expressing cells stained for DAPI (blue), anti-γH2AX (green). CCFs are indicated by arrows and
quantified. Scale bar, 5 μm.Graph showsmean± SEMofn= 3 independent experiments.P-valuewas calculated byunpaired two-tailed Stu-
dent’s t-test. (∗∗∗∗) P<0.0001. (I ) The expression of the indicated SASP componentswasmonitored byRT-qPCR in proliferating (Prolif) and
senescent (IR) Parkin-expressing cells. Data are mean±SEM of n =3 independent experiments. P-value was calculated by unpaired two-
tailed Student’s t-test. (∗∗∗) P <0.001; (∗∗) P<0.01. (J) Heat map of RNA-seq analysis of SASP genes in the depicted IMR90 cells from n=3
independent experiments. The color intensity represents the Z-score of the mean FPKM expression, where red indicates highly and blue
lowly expressed. (K ) Lysates from proliferating (Prolif) and senescent (IR) of control (C) and Parkin-expressing (P) cells were probed for
the expression of IL8 by immunoblotting.
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on SASP gene expression: The induction of IL1α, IL1β,
IL6, and IL8 mRNAs was drastically impaired in mito-
chondria-depleted senescent cells, determined by qPCR
(Fig. 1I; Supplemental Fig. S1E). We thus performed
RNA-seq on control and Parkin-expressing proliferating
cells and control and Parkin-expressing senescent cells
treatedwith or without CCCP. Principal component anal-
ysis (PCA) showed clear separation of the mitochondria-
depleted senescent cells (Parkin IR CCCP) from the other
five treatment groups, along the first principal component
(Supplemental Fig. 1F). Differential gene expression
analysis showed that senescence-associated expression
changes of 3466 genes were abrogated in senescent cells
depleted of mitochondria (Parkin IR CCCP) compared
with control senescent cells (Parkin IR). Specifically,
1505 genes were up-regulated in senescent cells (Parkin
IR–Parkin Prolif) and down-regulated upon mitochondria
removal (Parkin IR CCCP–Parkin IR), whereas 1961 genes
were down-regulated in senescent cells (Parkin IR–Parkin
Prolif) and up-regulated upon mitochondria clearance
(Parkin IR CCCP–Parkin IR) (Supplemental Fig. S1G). By
analyzing the SASP components and genes associated
with cell cycle progression, we confirmed that Parkin-me-
diated mitophagy strongly attenuated the SASP expres-
sion (Fig. 1J) without reversing the senescent growth
arrest (Supplemental Fig. S1H). As an additional confirma-
tion of SASP reduction at the mRNA level in senescent
cells depleted ofmitochondria, we performed gene expres-
sion analysis using a custom NanoString panel targeting
31 SASP mRNAs (Coppé et al. 2010). Most SASP mRNAs
that were significantly up-regulated in senescent cells
(Parkin IR)were down-regulated uponmitochondria clear-
ance (Parkin IR CCCP) (Supplemental Fig. S1I). Analysis
at the protein level by IL8 immunoblotting also showed
the ability of mitochondria clearance to dampen the
SASP (Fig. 1K).
To confirm that these results were not unique to the
IR-induced senescence model, we removed mitochondria
in cells induced to enter senescence by the DNA damag-
ing agent etoposide. Specifically, control and Parkin-
expressing cells were exposed to etoposide for 24 h, and
after 2 d cells were treated with or without CCCP. Par-
kin-mediated mitophagy led to elimination of mitochon-
dria in senescent cells (Supplemental Fig. S1J), again
without reversing the senescence growth arrest (Supple-
mental Fig. S1K). Similar to the IR model, clearance of
mitochondria prevented formation of CCFs (Supplemen-
tal Fig. S1L) and abrogated expression of the SASP (Supple-
mental Fig. S1M). Taken together, our results indicate
that mitochondria are required for the formation of
CCFs and hence the SASP program.
Mitochondria–ROS–JNK signaling pathway drives CCFs
and the SASP
Wenext sought to define the mechanisms by whichmito-
chondria trigger formation of CCFs. Because dysfunc-
tional mitochondria increase ROS production (Fig. 1C;
McCubrey et al. 2006; Schieber and Chandel 2014)
and it has been shown that ROS control the SASP
(Nelson et al. 2018), we investigated whether ROS pro-
mote CCF formation. Mitochondria-deficient senescent
cells showed significantly reduced mitochondrial ROS
production when compared with control senescent cells
treated with CCCP (Fig. 2A), consistent with the idea
that mitochondria signal to CCFs via ROS. To directly
test this, we elevated or reduced cellular ROS levels and
examined the corresponding effects on CCFs. First, we
nonspecifically elevated cellular ROS levels in proliferat-
ing IMR90 cells by hydrogen peroxide (H2O2) (Fig. 2B).
This procedure triggered cell cycle arrest, as judged by
loss of ph-Rb and cyclin A and induction of p21 (Fig.
2C), as well as CCFs and the SASP (Fig. 2D,E). Second,
we specifically increased mitochondrial ROS by MitoPar-
aquat (Fig. 2F; Robb et al. 2015), which again triggered
growth arrest (Fig. 2G) and induced formation of CCFs
(Fig. 2H) and expression of the SASP genes (Fig. 2I). Third,
conversely, we suppressed mitochondrial ROS withmito-
chondrial antioxidant MitoQ (Fig. 2J). This strongly de-
creased both CCFs and the SASP in irradiated senescent
cells (Fig. 2K,L) without reverting senescence-associated
cell cycle arrest, assessed by EdU incorporation, prolifera-
tionmarkers including ph-Rb and cyclin A, and growth ar-
rest marker p21 (Fig. 2M,N). Taken together, these results
indicate that elevated mitochondrial ROS induce forma-
tion of CCFs.
We next investigated the mechanism by which ROS in-
duce CCF formation. ROS can promote the activation of
the stress-activated JNK kinase (McCubrey et al. 2006;
Schieber and Chandel 2014; Shi et al. 2014). Therefore,
we set out to test whether ROS signal to CCFs via JNK.
In linewith this idea, JNKwas activated in senescent cells
(Fig. 3A) and suppressed in mitochondria-depleted senes-
cent cells as well as in MitoQ-treated senescent cells
(Supplemental Fig. S2A,B), supporting the mitochon-
dria–ROS–JNK signaling pathway. To directly test wheth-
er JNK activity is required for CCF formation and
induction of the SASP, we treated IMR90 cells with JNK
inhibitor SP600125 and then induced cells to senesce by
IR. Like parkin-directed mitophagy, JNK inhibition did
not affect several senescence markers, including loss of
ph-Rb and cyclin A and induction of p21 (Fig. 3B), but it
did compromise accumulation of CCFs and induction of
representative SASP genes assessed by qPCR (Fig. 3C,D).
As an additional confirmation of SASP reduction upon
JNK inhibitor treatment, we performed targeted gene ex-
pression profiling of proliferating and senescent cells,
with or without JNK inhibitor, via a NanoString panel
probing 249 inflammatory genes. PCA analysis showed
that JNK inhibitor-treated senescent cells are more simi-
lar to proliferating cells (Fig. 3E). Differential expression
analysis showed that 84 of the 249 genes are up-regulated
in senescence and 64 of these were down-regulated in sen-
escent cells treated with JNK inhibitor. Suppressed genes
included all SASP genes (Freund et al. 2010) on the panel
(Fig. 3F) and a slew of other senescence-up-regulated in-
flammation genes (Supplemental Fig. S2D). JNK inhibitor
treatment also diminished the SASP at the protein level in
senescent cells, as shown by IL8 immunoblotting (Fig.
3G). Importantly, inhibition of JNK did not suppress
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Figure 2. ROS promote formation of CCFs and expression of the SASP. (A)Mitochondrial reactive oxygen species (mROS)weremeasured
by flow cytometry usingMitoSOX (5 μM) in proliferating and senescent (IR) of control and Parkin-expressing cells with or without CCCP
treatment 10 d after IR. For raw data, see Supplemental Figure S7. (B) Proliferating IMR90 cells were exposed to exogenous ROS (H2O2, 600
μM) for 2 h. Quantification ofmitochondrial reactive oxygen species (mROS)was assessed by flow cytometry usingMitoSOX (5 μM) at day
4. For raw data, see Supplemental Figure S7. (C–E) Proliferating IMR90 cells exposed to exogenous ROS (H2O2, 600 μM) and harvested at
the indicated times were analyzed for the depicted proteins by immunoblotting (C ), quantified for CCFs (D), and analyzed for the expres-
sion of SASP components by RT-qPCR (E). Data shown in A, B, D, and E are mean±SEM of n =3 independent experiments. P-value was
calculated by unpaired two-tailed Student’s t-test or one-way ANOVA coupled with Dunnett’s test. (∗∗∗∗) P <0.0001; (∗∗∗) P <0.001; (∗∗) P <
0.01; (∗) P <0.05; (NS) not significant. (F–I ) Proliferating IMR90 cells treated withMitoPQ (40 μM) for 8 d were analyzed for mitochondrial
superoxide production by flow cytometry using MitoSOX (5 μM) (for raw data, see Supplemental Figure S7) (F ), probed for the indicated
proteins by immunoblotting (G), quantified forCCFs (H), and assessed for expression of the indicated SASP genes byRT-qPCR (I ). For F,H,
and I, data aremean±SEMof n= 3 independent experiments.P-valuewas calculated by unpaired two-tailed Student’s t-test. (∗∗∗) P<0.001;
(∗∗) P<0.01; (∗) P<0.05. (J–N) IMR90 cells were treatedwith 100 nMMitoQ and then irradiated to initiate senescence. Cells were harvested
after 10 d of irradiation. (J) Quantification of mitochondrial reactive oxygen species (mROS) by flow cytometry using MitoSOX (5 μM) in
proliferating and senescent (IR) with or without MitoQ. For raw data, see Supplemental Figure S7. (K ) Formation of CCFs was monitored
by immunofluorescence, imaged, and quantified in proliferating and senescent (IR) IMR90 cells treatedwith or withoutMitoQ. Represen-
tative fluorescent images are shown. CCFs are indicated by arrows. Scale bar, 8 μm. (L) Expression of the selected SASP genes was mea-
sured by RT-qPCR in proliferating and senescent (IR) IMR90 cells treated with or without MitoQ. Mean±SEM of n=3 independent
experiments are shown in J–L. P-value was calculated by unpaired two-tailed Student’s t-test. (∗∗∗∗) P<0.001; (∗∗∗) P< 0.001; (∗∗) P<
0.01; (∗) P <0.05. (M ) The effect of MitoQ on cell proliferation was assessed by EdU incorporation. Representative images and quantifica-
tion from two independent experiments are shown. Scale bar, 15 μm. (N) Lysates fromproliferating and senescent (IR) IMR90 cells with or
without MitoQ were analyzed for the indicated proteins by immunoblotting.
Vizioli et al.
432 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on October 27, 2021 - Published by genesdev.cshlp.orgDownloaded from 
mitochondrial ROS (Fig. 3H), in line with the idea that
ROS act upstream of JNK activation. The effects of the
JNK inhibitor were validated using shRNAs targeting
JNK1 and JNK2. Knockdown of JNK1/2 strongly reduced
CCF accumulation and the expression of SASP genes in
senescent cells (Fig. 3I–K). Finally, inhibition of JNK in al-
ready senescent cells (9 d after IR) (Supplemental Fig. S2F)
also resulted in reduction of CCFs and down-regulation of
the SASP (Supplemental Fig. S2G,H) but did not rescue







Figure 3. JNKmediates formation of CCFs and expression of the SASP. (A) Proliferating (Prolif) and senescent (IR) IMR90 cells harvested
at the indicated times were analyzed for ph-JNK and JNK by immunoblotting. (B–H) IMR90 cells were treated with JNK inhibitor (JNKi,
SP600125, 20 μM) and then irradiated to induce senescence. Cells were harvested 10 d after IR. (B) Immunoblot analysis of the indicated
proteins in proliferating (Prolif) and senescent (IR) IMR90 cells with or without JNKi. (C ) Proliferating (Prolif) and senescent cells (IR) with
or without JNKi were imaged and quantified for CCF formation. CCFs are indicated by arrows. Scale bar, 8 μm. (D) Expression of the SASP
measured by RT-qPCR in the depicted IMR90 cells. (E) Principal component analysis scatter plot showing the global gene expression of
the cohorts used in the NanoString analysis. (F ) Heat map of SASP genes included in the NanoString analysis in proliferating (Prolif) and
senescent (IR) with or without JNKi. Mean of three independent replicates is shown. The color intensity represents the Z-score of the
mean FPKM expression. (G) Immunoblot analysis of IL8 in proliferating and senescent (IR) IMR90 cells in the absence or presence of
JNKi. (H) Determination of mitochondrial reactive oxygen species (mROS) by flow cytometry usingMitoSOX (5 μM) in proliferating (Pro-
lif) and senescent (IR) IMR90 cells, in the absence or presence of JNKi. The percentage of positive cells is shown. For raw data, see Sup-
plemental Figure S7. Data shown in C,D, and H are mean±SEM of three independent experiments. P-value was calculated by unpaired
two-tailed Student’s t-test. (∗∗∗) P<0.001; (∗∗) P<0.01; (∗) P <0.05. (I–K ) Proliferating IMR90 cells were infectedwith a nontargeting control
shRNA (sh-NTC) or with shRNA against JNK1/2 (sh-JNK1/2), followed bymock (Prolif) or ionizing irradiation (IR). Ten days after IR, cells
were assessed for expression of JNKby immunoblotting (I ) or percentage of CCF-positive cells by immunofluorescence (J) ormonitored for
the expression of the indicated SASP genes by RT-qPCR (K ). Data shown in J and K are mean± SEM of three independent experiments.
Statistical significance was calculated using unpaired two-tailed Student’s t-test. (∗∗) P<0.01; (∗) P<0.05.
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our hypothesis that JNKmediates CCFs and the SASP. To-
gether, these data show that a mitochondria–ROS–JNK
signaling pathway drives CCF formation and hence the
SASP.
53BP1 controls formation of CCF in the nucleus
Wenext sought to investigate the nuclear events that gen-
erate CCFs and the connection to JNK. Currently, the
mechanisms that initiate CCFs in the nucleus are not
well understood. A clue is provided from our previous
study investigating themolecularmarkers of CCFs,where
we found that CCFs stain negative for 53BP1 (Fig. 4A; Iva-
nov et al. 2013). This observation is unusual, as CCFs are
enriched in γH2AX, and γH2AX and 53BP1 typically
colocalize (Kleiner et al. 2015). We therefore suspected
that 53BP1 might be a regulated inhibitor of CCF for-
mation. We speculated that JNK signals to 53BP1 and
promotes CCF formation. Concordant with this idea,
coimmunoprecipitation analysis showed that a 53BP1-
JNK interaction occurs between the endogenous proteins
in senescent cells but not in proliferating cells (Fig. 4B).
To directly test whether 53BP1 negatively regulates
CCF formation, we stably suppressed 53BP1 by shRNA
and then induced senescence by IR (Fig. 4C). Knockdown
of 53BP1 led to elevated CCFs and SASP (Fig. 4D,E) with-
out affecting the senescence-associated cell cycle arrest
(Supplemental Fig. S3A). We then stably overexpressed
53BP1 in IMR90 cells and induced senescence by IR.
While overexpression of 53BP1 did not impair the senes-
cence growth arrest, reflected in loss of ph-Rb and abun-
dance of p21 (Fig. 4F), it markedly and significantly
suppressed induction of CCFs and the SASP (Fig. 4G–I).
Taken together, these results, notably 53BP1’s exclusion
from CCFs, its senescence-specific interaction with
JNK, and its ability to increase or decrease CCFs when ec-
topically expressed or knocked down, suggest that 53BP1
is a JNK-regulated inhibitor of CCF formation.
At the molecular level, 53BP1 inhibits double-strand
break (DSB) end resection (Zimmermann and de Lange
2014), suggesting that DSB end resection is required for
CCF formation. To test this idea, we directly inhibited
DSB end resection byMirin, an inhibitor of MRE11-medi-
ated end resection (Dupré et al. 2008). Upon IR-induced
senescence, as expected, Mirin suppressed γH2AX (Dupré
et al. 2008), as shown by immunoblotting (Supplemental
Fig. S3B). Strikingly, Mirin inhibited formation of CCFs
and the SASP (Supplemental Fig. S3C,D), supporting the
idea that 53BP1 suppresses CCFs by restraining DSB end
resection. Future studies are needed to decipher the specif-
ic regulation of 53BP1 by JNK and the role of end resection
in CCF formation.
HDAC inhibitors improve mitochondria function and
suppress formation of CCFs and expression of the SASP
Given the important role of mitochondria as drivers
of CCFs and the SASP, we considered the possibility
that drugs could be used to restore mitochondria function
and hence suppress CCFs and the SASP in senescent cells.
Already we showed that JNK andMRE11 inhibitors block
mito–nuclear signaling to suppress CCFs and the SASP
(Fig. 3; Supplemental Figs. S2, S3). We showed above
that nuclear-encoded mitochondrial oxidative phosphor-
ylation genes were down-regulated in senescent cells
(Fig. 1A; Supplemental Fig. S1A), and this is linked to mi-
tochondria dysfunction (Fig. 1B–D). We speculated that
this decrease in expressionmight be rescued by treatment
with histone deacetylase inhibitors (HDACi), agents that
often increase expression of genes by increasing histone
acetylation (Haberland et al. 2009). We therefore ex-
amined whether HDACi can antagonize repression of nu-
clear-encoded mitochondrial oxidative phosphorylation
genes and improve mitochondria function in senescence.
As expected, in senescent IMR90 cells, Trichostatin A
(TSA) treatment increased histone acetylation in a dose-
dependent manner, as shown by immunoblotting for
H4K16ac (Fig. 5A,B; Sharma et al. 2010). For subsequent
experiments, we used 100 nM TSA, a dose substantially
below that typically found to be cytotoxic to cancer cells
(Venkataramani et al. 2010; Khan and La Thangue 2012).
This low dose of TSA was nontoxic, in contrast to higher
doses, which were preferentially toxic to senescent cells
compared with proliferating cells (i.e., senolytic, as noted
previously for HDACi) (Supplemental Fig. S4A,B; Di
Micco et al. 2011). Low-dose TSA did not revert the senes-
cence-associated growth arrest, reflected in EdU incorpo-
ration and analysis of proliferation markers, including
ph-Rb, cyclin A, and p21 (Fig. 5C,D). To verify this result,
we performed RNA-seq on proliferating and senescent
cells, pretreated with or without TSA. PCA showed
separation of the four treatment groups (Supplemental
Fig. S4C). However, analysis of expression of cell cycle
promoting genes in RNA-seq data confirmed that TSA
treatment of senescent cells did not rescue the prolifera-
tion arrest (Supplemental Fig. S4D). These results indicate
that TSA does not affect repression of cell cycle genes nor
the cell cycle arrest characteristic of senescence.
In contrast, examination of expression of nuclear-
encoded mitochondrial oxidative phosphorylation genes
demonstrated a general increase in their expression in
TSA-treated senescent cells, shifting the expression pro-
file in TSA-treated senescent cells toward that of proli-
ferating cells (Fig. 5E). GSEA also revealed significant
up-regulation of these genes in TSA-treated senescent
(IR) cells (Supplemental Fig. S4E). We confirmed this
observation by qPCR of mRNA transcripts. Nuclear-en-
coded oxidative phosphorylation mRNAs (NDUFA10,
NDUFA12, NDUFC2, and NDUFS8) were higher in
TSA-treated senescent cells relative to the control senes-
cent cells (Fig. 5F). Similarly, protein levels of nuclear-en-
coded NDUFB8 and SDHA genes were increased by TSA
treatment (Fig. 5G). Concomitant with this, TSA signifi-
cantly increased mitochondria membrane potential (Fig.
5H), decreased mitochondrial ROS (Fig. 5I), and lowered
expression of ROS-responsive gene SOD2 (Fig. 5J).
NFE2L2 (NRF2) is a master regulator of cellular redox ho-
meostasis (Ma 2013). A subset of NRF2 target genes was
up-regulated in senescence, and some of these were
down-regulated by TSA (Supplemental Fig. S4F), also
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consistent with a model whereby TSA suppresses mito-
chondria dysfunction.
We next asked whether TSA suppressed CCFs and the
SASP in senescent cells. TSA treatment significantly de-
creased accumulation of CCFs in senescent cells (Fig.
5K). Consistent with this, TSA also strongly reduced the
expression of key SASP genes, including IL1α, IL1β, IL6,
and IL8 (Fig. 5L). Suppression of the SASP by HDACi
was confirmed by RNA-seq. Overall, TSA antagonized
the effect of senescence on expression of 606 genes (471
genes up-regulated in senescence (IR) and down-regulated
by TSA (IR TSA); 135 down-regulated in senescence (IR)
and up-regulated by TSA (IR TSA) (Supplemental Fig.
S4G). Gene Ontology (GO) analysis of the 471 senes-
cence-induced genes down-regulated by TSA identified








Figure 4. 53BP1 controls formation of CCFs in the nucleus. (A) Confocal fluorescent images of senescent (IR) IMR90 cells stained for
DAPI (blue), γH2AX (green), and 53BP1(red) 10 d after IR. CCFs are indicated with arrows. Scale bar, 10 μm. (B) Immunoblot analysis
for 53BP1 and JNK after immunoprecipitation of 53BP1 from proliferating (Prolif) and senescent (IR) IMR90 cells 10 d after IR. One rep-
resentative experiment out of four experiments is shown. (C–E) Proliferating IMR90 cells were infected with a nontargeting control
shRNA (sh-NTC) or with shRNA against 53BP1 (sh-53BP1), followed by mock (Prolif) or ionizing irradiation (IR). Ten days after IR, cells
were analyzed for expression of 53BP1 by immunoblotting (C ), stained and quantified for formation of CCF (indicated by arrows) (D), or
examined for the expression of SASP components by RT-qPCR (E). Scale bar, 10 μm. Mean±SEM of three independent experiments is
shown in D and E. Statistical significance was calculated using unpaired two-tailed Student’s t-test. (∗) P <0.05; (NS) not significant.
(F–I ) IMR90 cells were infected with lentivirus directing expression of 53BP1 or control, induced to senesce by irradiation (IR) or control
(Prolif). Ten days after IR, cells were analyzed for the depicted proteins by immunoblotting (F ), stained and quantified for CCFs (indicated
by arrows) (G), assessed for the indicated SASP genes by RT-qPCR (H), or probed for the expression of IL8 by immunoblotting (I ). Scale bar,
6 μm. Data shown in G and H represent mean± SEM of three independent experiments. P-values were calculated by unpaired two-tailed
Student’s t-test. (∗∗∗∗) P<0.0001; (∗∗∗) P <0.001; (∗∗) P< 0.01.
Mitochondria-to-nucleus triggers inflammation
GENES & DEVELOPMENT 435










Figure 5. HDAC inhibitors improve mitochondria function and suppress formation of CCFs and expression of the SASP. (A) Scheme of
experimental design in B–M. (B) Proliferating or senescent (IR) IMR90 cells treated with TSA at indicated dose range (20–50–100 nM)were
analyzed for H4K16ac andH4 by immunoblotting. (C ) The effect of TSA (100 nM) on cell proliferationwas assessed by EdU incorporation.
Representative fluorescent images and quantification are shown. Scale bar, 10 μm. (D) Lysates fromproliferating (Prolif) and senescent (IR)
IMR90 cells with or without TSA (100 nM) were analyzed for the indicated proteins by immunoblotting. (E) Relative fold change in nu-
clear-encoded oxidative phosphorylation genes (KEGGhsa00190; subunits of complexes I–V)was represented in a histogramwith bin size
of 0.1 log2 fold change units. Counts in each bin were normalized to total number of nuclear-encoded mitochondrial genes detected.
(F ) The expression of the indicated nuclear-encoded mitochondrial genes was analyzed by RT-qPCR in senescent cells (IR) treated
with or without TSA (100 nM). (G) Proliferating (Prolif) and senescent (IR) cells treated with or without TSA (100 nM) were analyzed
for the indicated proteins by immunoblotting. (H) Proliferating (Prolif) and senescent (IR) cells treated with or without TSAwere incubat-
ed with TMRE (100 nM) and Mitotracker Green (MTG; 100 nM) and analyzed by flow cytometry. The ratio of TMRE and MTG fluores-
cence intensity was used to representmitochondrialmembrane potential (MMP). (I ) Senescent (IR) IMR90 cells with or without TSA (100
nM) were incubated with MitoSOX (5 μM) and analyzed by flow cytometry for mitochondrial reactive oxygen species. Percentage of pos-
itive cells is shown. For rawdata, see Supplemental Figure S8. (J) Expression of ROS-responsive gene SOD2was determined byRT-qPCR in
proliferating (Prolif) and senescent (IR) IMR90 cells with or without TSA (100 nM). (K,L) Proliferating (Prolif) and senescent (IR) cells treat-
edwith orwithout TSA (100 nM)were imaged by confocalmicroscope and quantified for formation of γH2AX-positiveCCFs (indicated by
arrows) (K ) ormonitored for the expression of indicated SASP genes byRT-qPCR (L). Scale bar, 8 μm.Data shown inC, F, andH–L aremean
±SEM of three independent experiments. Statistical analysis was performed with unpaired two-tailed Student’s t-test. (∗∗∗∗) P< 0.0001;
(∗∗∗) P <0.001; (∗∗) P <0.01; (∗) P <0.05. (M ) Heat map of RNA-seq analysis of SASP genes in the indicated IMR90 cells from n =3 indepen-
dent experiments. Color intensity represents the Z-score of mean FPKM expression.
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immune response, response to wounding, inflammatory
response, and cytokine activity (Supplemental Fig. S4H).
In fact, specific analysis of SASP factors confirmed that
TSA blunted the expression of most of them (Fig. 5M).
The ability of TSA to impair the SASP was also observed
at the secreted protein level in the conditioned medium
by immunoblotting for IL8 (Supplemental Fig. S4I).
We also tested a second HDAC inhibitor, Vorinostat
(SAHA), already approved for use in humans, for example,
against cutaneous T-cell lymphoma (Mann et al. 2007).
IMR90 cells were treated with low doses of SAHA (as for
TSA, lower than doses typically investigated as cytotoxic
to cancer cells (Shi et al. [2017]) and induced to senesce by
IR. Treatment with SAHA reduced formation of CCFs
(Supplemental Fig. S4J) and attenuated induction of IL8,
without rescuing the senescence growth arrest (Supple-
mental Fig. S4K). We also treated IMR90 senescent cells
with TSA only after senescence was established (Supple-
mental Fig. S4L). In this setting, TSA also reduced forma-
tion of CCFs and expression of the SASPwithout affecting
cell cycle arrest (Supplemental Fig. S4M–O). In addition,
based on gene expression profiling by RNA-seq, there
was a marked overlap (3.7 times larger than predicted
from random; P< 0.001) between the effects of Parkin-me-
diated mitophagy and TSA on the senescence-associated
gene expression program. Most notably, ∼50% of the sen-
escence-regulated genes antagonized byTSAwere also an-
tagonized by Parkin-mediated mitophagy (Supplemental
Fig. S4P). This overlap is consistent with the view that
both mitophagy and TSA exert their effects, in part, by
eradication of dysfunctional mitochondria, the former
by their autophagic clearance and the latter by improving
their function. In sum, HDACi improve mitochondria
function and suppress CCF accumulation and the SASP
program.
Despite these data, it is well-documented that HDACi
can exert wide-ranging effects on cells (Xu et al. 2007).
Therefore, we considered the possibility that HDACi
might exert their effects on CCFs and the SASP by other
mechanisms, aside fromimprovedmitochondria function.
HDACi did not affect proinflammatory signaling byCCFs,
once present in the cytoplasm. As a CCF mimetic, trans-
fection of cellswithDNAor chromatin activates cytoplas-
mic cGAS and the SASP (Dou et al. 2017). Secretion of IL8
induced by transfection of chromatin fragments into pro-
liferating cells was not inhibited in the presence of TSA
(Fig. 6A), suggesting that TSA did not desensitize CCF
sensing and the cGAS/STING signaling pathway. Aside
fromtheCCF–cGAS–STINGpathway, variousothereffec-
tors have been implicated in SASP activation in senescent
cells, including DNA damage, p38MAPK and mTOR as
upstream drivers, and NFκB and C/EBPβ as proximal tran-
scription factors (Acosta et al. 2008; Kuilman et al. 2008;
Orjalo et al. 2009; Freund et al. 2011; Laberge et al. 2015;
Herranz and Gil 2018). To gauge the specificity of HDACi
for inhibitionof the SASPby targetingof dysfunctionalmi-
tochondria, we assessed these other known SASP induc-
ers. We found that TSA did not significantly alter DNA
damage signaling, at least as reflected in the number of
intranuclear γH2AX foci in senescent cells (Fig. 6B). Like-
wise, TSA did not inhibit p38MAPK and the mTOR path-
way, as judged by phosphorylation of p38MAPK and S6,
respectively (Fig. 6C,D). We next tested the possibility
that TSA interfered with the NFκB signaling axis, thereby
preventing SASP activation. In senescent cells, IL1α binds
its receptor (IL1R1) and activates a signaling cascade that
leads to degradation of IRAK1 and nuclear translocation
of NFκB (Orjalo et al. 2009). We examined IRAK1 protein
levels in cells treated with or without TSA and induced
to senesce by IR (Fig. 6E). In the absence of TSA, IRAK1
was reduced and IL8 increased in response to irradiation,
indicating activated IL1R1 and NFκB signaling, while in
the presence of TSA the levels of IL8 decreased and
IRAK1 increased, suggesting suppression of IL1R1 and
NFκB signaling (Fig. 6E,F). However, when irradiated sen-
escent cells were exposed to recombinant IL1α, TSA did
not prevent the further down-regulation of IRAK1 (Fig.
6E) as well as the secretion of IL8 (Fig. 6F), suggesting
that TSA did not suppress the SASP by making the NFκB




Figure 6. Effects of HDAC inhibitors on other path-
ways. (A) Proliferating IMR90 cells were transfected
with chromatin fragments and treated with TSA as in-
dicated. On day 4, conditioned medium (CM) was col-
lected and analyzed for IL8 by immunoblotting.
(B) Proliferating (Prolif) and senescent (IR) cells with
or without TSA as in Figure 5A were immunostained
for γH2AX. Shown is the percentage of cells with
more than three intranuclear γH2AX foci. Data are
mean±SEM of three independent experiments. Statis-
tical analysis was performed with unpaired two-tailed
Student’s t-test. (∗∗) P <0.01; (NS) not significant.
(C ) Proliferating and senescent (IR) IMR90 cells treat-
ed as in Figure 5A were analyzed for phospho-p38 (p-
p38) and p38 by immunoblotting. (D) Immunoblot
for phospho-S6 (p-S6) and S6 in proliferating and senes-
cent (IR) cells 10 d after IR. (E,F ) IMR90 cells were
treated with TSA, irradiated to induce senescence, and incubated with recombinant IL1α (r-IL1α) as indicated. (E) Cell lysates were ana-
lyzed for the indicated proteins by immunoblotting 10 d after IR. (F ) Conditioned medium (CM) was collected and probed for IL8 by im-
munoblotting 10 d after IR.
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results demonstrate a new class of agents able to target
the senescence-associated inflammation, namely HDAC
inhibitors. HDAC inhibitors preferentially improve
mitochondria function and accordingly are potent sup-
pressors of both CCF and SASP.
HDAC inhibitors suppress inflammation in vivo
Next we investigated the ability of HDAC inhibitors to
suppress the SASP and inflammation associated with sen-
escence and mitochondria dysfunction in vivo. We and
others have shown that sublethal IR induces senescence,
CCF formation, and the SASP in mouse liver (Dou et al.
2017; Glück et al. 2017). To test the ability of HDACi to
suppress the SASP in this in vivo model, young adult (9-
wk-old) C57BL/6 mice were administered vehicle (HPO-
β-CD) or SAHA in drinking water for 1 d before IR and 7
d after IR (Fig. 7A). Liver samples were harvested at day
8 and analyzed by immunoblotting and immunohisto-
chemistry. SAHA-treated mice showed increased histone
acetylation (Fig. 7B,C). SAHA did not significantly atten-
uate the DNA damage marker γH2AX (Fig. 7D), similar
to our in vitro results (Fig. 6B), and as expected since
DNA damage is proximal to IR in this model. In contrast,
SAHA strongly suppressed the induction of IL1α com-
pared with vehicle-treated mice (Fig. 7D).
To test the protective effect of HDACi in a model of
mitochondria dysfunction, we took advantage of an estab-
lishedmousemodel of mitochondria redox stress-induced
liver injury, caused by acetaminophen (APAP) overdose.
The toxicity of APAP is initiated by production of reactive
metabolite N-acetyl-p-benzoquinone imine (NAPQI),
which depletes glutathione and covalentlymodifies mito-
chondrial proteins. This, in turn, causes mitochondrial
oxidative stress and activation of JNK (Ramachandran
and Jaeschke 2017), events that we have shown trigger
CCF formation and the SASP in senescent cells in vitro.
Indeed, it has been recently shown thatAPAP-induced liv-
er injury is also associated with the induction of senes-
cent-like cells, reflected by SA-β-gal and γH2AX, and
increased expression of p21 and p16, as well as growth ar-
rest and expression of the SASP (Bird et al. 2018). To probe
the effects of HDACi on responses to APAP, we injected
young (9-wk-old) C57BL/6 mice with TSA or DMSO 1 d
before and simultaneously with APAP administration
(here, we used TSA to complement the previous in vivo
experiments with SAHA). TSA prevented CCF and SASP
induction, assessed 48 h after APAP administration by
staining for γH2AX and IL1α, respectively (Fig. 7E; Supple-
mental Fig. S5A). Consistent with a propagating role for
SASP-mediated secondary senescence (Bird et al. 2018),
TSA also markedly reduced p21 and intranuclear γH2AX
levels induced by APAP exposure (Fig. 7F; Supplemental
Fig. S5B).
We next harvested liver tissue after APAP dosing and
performed RNA-seq, using four mice per cohort. PCA
showed separation of the four cohorts based on gene
expression (Supplemental Fig. S5C). Consistent with our
in vitro data (Fig. 5E–G), RNA-seq analysis of nuclear-en-
coded oxidative phosphorylation genes revealed that TSA
antagonized their global down-regulation in liver of
APAP-treated mice after drug administration (Supple-
mental Fig. S5D,E). Analysis of all genes that are differen-
tially expressed showed that 1825 genes were affected
upon APAP treatment (1201 genes up-regulated and 624
genes down-regulated) (Supplemental Fig. S5F). Interest-
ingly, 445 genes whose expression was increased by
APAP were suppressed in APAP TSA-treated mice (Fig.
7G; Supplemental Fig. S5F). IPA analysis of these genes
showed NRF2 as one of the top upstream regulators that
is activated in APAP-treated mice and down-regulated
by TSA (Supplemental Fig. S5G). Upon oxidative stress,
NRF2 accumulates in the nucleus, promoting the expres-
sion of target genes, including Heme oxygenase 1
(Hmox1), Sulfiredoxin 1 (Srxn1), NAD(P)H dehydrogenase
(quinone) 1 (Nqo1), and Glutathione S-transferase 1
(GSTA1) (Walsh et al. 2014; Forootan et al. 2017). Specifi-
cally, ∼20 out of 76 documented NRF2 target genes
(Hayes and Dinkova-Kostova 2014) showed a trend to
up-regulation in APAP-treated mice (Fig. 7H), and TSA
suppressed the majority of these, including Cbr1, Ptgr1,
Nqo1, Gsta1, Gpx4, Srxn1, and Hmox1. These results
were confirmed by qPCR for selected NRF2 targets,
Gsta1,Hmox1,Nqo1, and Srnx1 (Fig. 7I). Tomore directly
ask whether TSA affects APAP-induced oxidative stress,
we stained liver tissues from APAP mice treated with or
without TSA with the lipid peroxidation product 4-hy-
droxy-2-nonenal (4-HNE). We found that TSA reduced
the levels of 4-HNE after APAP administration (Supple-
mental Fig. S5H). The observation that TSA suppresses
down-regulation of nuclear-encodedmitochondrial oxida-
tive phosphorylation genes, up-regulation of NRF2 target
genes, oxidative damage, CCFs, inflammation, and sec-
ondary senescence is consistent with the idea that TSA
exerts its effects by suppression of ROS and DNA damage
at the source—in other words, by countering mitochon-
dria dysfunction in this in vivo model.
Discussion
This work addresses a major challenge of research into
the biology of aging, specifically to define the molecular
relationships between the so-called hallmarks of aging
(López-Otín et al. 2013; Kennedy et al. 2014). To this
end, here, we charted a molecular pathway that links dys-
functional mitochondria to inflammatory signaling of
senescent cells. Specifically, we defined a novel mito-
chondria–nuclear retrograde signaling pathway that trig-
gers formation of CCFs, a trigger of the SASP. This
pathway is initiated by dysfunctional mitochondria pro-
ducing ROS, an activator of JNK kinase. JNK kinase’s ini-
tiation of CCF formation in senescent cells is linked to its
interaction with 53BP1, a negative regulator of DSB end
resection and CCF formation. Importantly, this pathway
is targetable by drug interventions, some of which show
promise as anti-inflammatory/prohealthy aging interven-
tions. As proof of this concept, we show here thatMRE11,
JNK, and HDAC inhibitors suppress CCF formation and
the SASP in senescent cells. Aside from their anticancer
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Figure 7. HDAC inhibitors suppress inflammation in vivo. (A) Scheme of experimental design in B–D. C57BL/6 mice were pretreated
with vehicle (HPO-β-CD) or SAHA (0.1 g/L) in drinking water, subjected to irradiation (IR, 4Gy), and administrated vehicle (HPO-β-
CD) or SAHA in drinking water for seven more days. Seven days after IR, livers were harvested. (B,C ) Livers were lysed and analyzed
for H4K16ac, H4, H3K9ac, andH3 by immunoblotting. (D) Livers were stained for γH2AX and IL1α and quantified. Representative immu-
nohistochemistry images are shown. N =5 mice. Data are the mean±SEM. Statistical significance was calculated using unpaired two-
tailed Student’s t-test. (∗) P< 0.05; (NS) not significant. Scale bar, 20 μm. (E) Livers frommice treated as indicated were harvested 48 h after
APAP administration, stained for γH2AX and IL1α. CCFs are indicated by arrows. The percentage of cells positive for CCFs and IL1α is
shown. Representative immunohistochemistry images are shown. N= 5 mice for DMSO; n =8 for APAP DMSO and APAP TSA. Scale
bar, 20 μm. Data represent the mean±SEM. Statistical analysis was performed with unpaired two-tailed Student’s t-test. (∗∗∗∗) P<
0.0001; (∗) P< 0.05. (F ) Livers from mice treated as indicated were harvested 48 h after APAP administration and stained for γH2AX
and quantified. Representative immunohistochemistry images are shown. N=5 mice for DMSO; n =8 for APAP DMSO and APAP
TSA. Scale bar, 20 μm. Data represent the mean±SEM. Statistical analysis was performed with unpaired two-tailed Student’s t-test.
(∗∗∗∗) P< 0.0001. (G,H) Livers were harvested 14 h after APAP injection, lysed, and subjected to RNA-seq analysis. (G) Heat map of
RNA-seq analysis showing all genes that are significantly up-regulated in APAPDMSOversus untreatedmice and significantly down-reg-
ulated in APAPTSAversus APAPDMSO.N =4mice per group. (H) Heatmap of RNA-seq analysis of NRF2 target genes inmice treated as
indicated, 14 h after APAPadministration.N= 4mice for cohort. Color intensities areZ-scores of themean FPKMexpression. (I ) RT-qPCR
analysis of NRF2 target genes in the liver of mice treated as indicated, 14 h after APAP administration. N=10 mice for group. Data rep-
resent the mean± SEM. Statistical analysis was performed with unpaired two-tailed Student’s t-test. (∗∗) P <0.01; (∗) P <0.05.
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activities (Falkenberg and Johnstone 2014), HDACi have
been previously reported to suppress inflammation and
extend the health span and life span in multiple animal
models (Hockly et al. 2003; Tao et al. 2004; Gao et al.
2009; Guan et al. 2009; Krishnan et al. 2011; Hull et al.
2016).However, the underlyingmechanisms are unknown.
Since we observe decreased nuclear-encoded mito-
chondrial oxidative phosphorylation gene expression in
senescent cells, our data is consistent with increased mi-
tochondrial mass due to decreased mitophagy in senes-
cent cells, as established previously in the literature
(Dalle Pezze et al. 2014; Korolchuk et al. 2017). Decreased
mitophagy is typically associatedwithmitochondrial dys-
function (Korolchuk et al. 2017; Pickles et al. 2018), hence
the decreasedmitochondriamembrane potential andROS
production in senescent cells. However, since mitochon-
dria ROS production results from electron leakage from
the electron transport change during oxidative phosphor-
ylation (Brand and Nicholls 2011), it is also tempting to
speculate that down-regulation of nuclear-encoded oxida-
tive phosphorylation genes is directly related to increased
ROS production in senescent cells.
By several measures, HDACi improve mitochondria
function, thereby suppressing oxidative stress, CCFs, and
the SASP, both in vitro and in vivo. Improved mitochon-
dria function correlates with specific up-regulation of nu-
clear-encoded mitochondrial oxidative phosphorylation
genes, compared with cell cycle genes whose senes-
cence-associated repression is unaffected by HDACi in
the in vitromodel. HDACi’s ability to increase expression
of oxidative phosphorylation genes may contribute to
their beneficial effects on mitochondria function. By per-
haps the simplest scenario, HDACi might act by increas-
ing histone acetylation at the oxidative phosphorylation
genes themselves (Haberland et al. 2009), thereby promot-
ing their expression. However,HDACi havemany nonhis-
tone substrates and pleiotropic effects on cells (Xu et al.
2007), so alternative more indirect mechanisms are
possible. For example, HDACi may also act to enhance
mitophagy, thereby also improving mitochondrial func-
tion. The relationship between expression of nuclear-
encoded oxidative phosphorylation genes and mitophagy
in senescence is unknown. Regardless of the specific
mechanism, the demonstration that HDACi can improve
mitochondria function is important because it may con-
tribute to the documented, but poorly understood, anti-
inflammatory and prolongevity effects of these drugs
(Hockly et al. 2003; Tao et al. 2004; Gao et al. 2009;
Guan et al. 2009; Krishnan et al. 2011;Hull et al. 2016). Fu-
ture studies are required to address outstanding questions.
In apparent contrast to the anti-SASP activity shown
here, TSA and other HDACi have been previously report-
ed to induce senescence or to kill senescent human cells.
Importantly, previous prosenescence or senolytic effects
of HDACi in human cells have been observed with sub-
stantially higher doses of HDACi thanwe found to inhibit
the SASP. Previous studies have employed >1 µM TSA,
whereas here we report anti-SASP activity at 0.05–0.5
µMTSA.We confirmed that higher doses of TSA are toxic
to senescent cells (Supplemental Fig. S4A,B). In sum, there
is a clear dose dependence, with anti-SASP activity at low
doses and senolytic activity at higher doses.
We acknowledge that unresolved issues remain; for ex-
ample, the precise regulatory interaction between JNK,
53BP1, and DSB end resection in CCF formation is un-
known at this stage, as is their relationship to other regu-
lators of CCFs, such as autophagy factor LC3 and nuclear
scaffold component lamin B (Dou et al. 2015). Regarding
the relationship between JNK and 53BP1, we speculate
that JNK kinase phosphorylates 53BP1 to modulate its
control of end resection and hence CCF formation. If
so, JNK kinase may also control 53BP1’s role in DNA re-
pair in senescent cells. Alternatively, the regulation of
CCFs by JNK-53BP1 may be separable from 53BP1’s
role in DNA repair. Ongoing and future studies will
address this.
To conclude, this study assimilates previously disparate
facets of the biology of senescence, defines a novel mito-
chondria-to-nucleus signaling pathway in senescent cells
that initiates formation of CCFs and the SASP, and dem-
onstrates the potential utility of this pathway as a target
for suppression of inflammatory responses.
Materials and methods
Cell culture
Human primary IMR90 fibroblasts were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Thermo Fisher Scientific),
supplemented with 10% fetal bovine serum (FBS), 100 U/mL
penicillin, 100 μg/mL streptomycin, and 2 mM glutamine at 37°
C in a humidified atmosphere with 5% CO2 and 3% oxygen. Hu-
man embryonic kidney HEK293 and Phoenix amphotropic cells
were grown in DMEM (Thermo Fisher Scientific), supplemented
with 10% foetal bovine serum (FBS), 100U/mL penicillin, 100 μg/
mL streptomycin, and 2 mM glutamine at 37°C in a humidified
atmosphere with 5% CO2 and 20% oxygen. Cells were regularly
checked to confirm absence of mycoplasma contamination.
Induction of senescence
Proliferating IMR90 cells at∼40%–50%confluencywere induced
to senesce by X-ray irradiation with 20 Gy and allowed to recover
overnight. The media were then replaced, and cells were trypsi-
nized and split 1:4 2 d later; cells were analyzed at day 10. Alter-
natively, IMR90 cells at ∼60%–70% confluency were induced to
senesce by incubation with 600 μM H2O2 (Sigma-Aldrich) in se-
rum-free media for 2 h or with 40 μM MitoParaquat (MitoPQ,
Abcam) for 9 d. For etoposide-induced senescence, IMR90
cells at ∼60%–70% confluency were treated with 50 μM for
24 h. The media were then refreshed, and cells were harvested
at day 8.
Retroviral and lentiviral infection
Retroviral LZRS or LZRS-YFP_Parkin (a kind gift from Dr. Ste-
phen Tait, University of Glasgow, UK) and pLPC-N Myc (Addg-
ene 12540) or N-Myc-53BP1 WT pLPC (Addgene 19836)
constructs were used to transfect a Phoenix packaging cell line.
Lentiviral pLKO constructs along with packaging plasmids
were used to transfect HEK293T cells. Phoenix and HEK293T
cells were seeded at 70% confluency and transfected using Lipo-
fectamine 2000 (Thermo Fisher Scientific). Six hours later, the
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transfectionmediumwas replaced by new culturemedium.At 24
h after transfection, viral supernatant was filtered through a 0.45-
μm-pore-size PVDF filter (Millipore),mixedwith new cultureme-
dium in the proportion 1:1, supplemented with 8 μg/mL poly-
brene and added to recipient cells for 20 h. The infected cells
were selected with either 250 μM zeocin (Thermo Fisher Scien-
tific; for LZRS and LZRS-YFP_Parkin) or 1 μg/mL puromycin
(Thermo Fisher Scientific; for PLPC-N Myc, N-Myc-53BP1
WT pLPC and pLKO constructs). pLKO-based shRNA was from
Dharmacon. The following shRNAs were used: MAPK8 (JNK1,
TRCN0000001055), MAPK9 (JNK2, TRCN000000943), and
TP53BP1 (TRCN0000018865).
Treatments
For mitochondrial depolarization, LZRS and YFP-Parkin cells
were treated for 48 h with 12.5 μMCCCP (Sigma-Aldrich), 2 d af-
ter irradiation or etoposide treatment.
Antioxidant treatment was performed daily in irradiated cells
treated 8 h before irradiation with 100 nM MitoQ (MedKoo Bio-
science) for 10 d. Unless stated otherwise, for JNK inhibition cells
were treated daily for 8 h before the irradiation with 20 μM
SP600125 (Selleck Chemicals) for 10 d. For MRE11 inhibition,
cells were treated with 100 μMMirin (Selleck Chemicals) imme-
diately after the irradiation for 10 d. The following HDAC inhib-
itors were used: 100 nM Trichostatin A (TSA) (Sigma- Aldrich)
and Vorinostat (SAHA) (SelleckChemicals) at the indicated doses
were added 8 h before the irradiation for 10 d, unless stated other-
wise. Drugs were replaced daily. Recombinant human IL1α pro-
tein (R&D Systems) was added to irradiated cells at 20 ng/mL
for 24 h in serum-free medium.
Conditioned medium
Cells were cultured in serum-free medium for 24 h. The cultured
mediawere then collected, and the cell numberswere counted for
normalization. Themedia were filtered with 0.45-μmPVDF filter
(Millipore) to remove cells and debris. The resulting supernatant
was concentrated with a 5000MWCO spin concentrator (Agilent
Technologies) and analyzed by immunoblotting.
Antibodies
The following antibodies were used: NDUFB8 (Abcam
ab110242), SDHA (Cell Signaling Technology 11998), UQCR2
(Abcam ab14745), Tom20 (Santa Cruz Biotechnology sc-11415),
p-Rb ser807/811 (Cell Signaling Technology 9308), CyclinA (San-
ta Cruz Biotechnology sc-751), p21 (Santa Cruz Biotechnology sc-
471 and HUGO 291 Abcam ab107099), IL8 (Abcam ab18672), p-
JNK Thr183/Tyr188 (Cell Signaling Technology 9251), JNK
(Cell Signaling Technology 9252 and Santa Cruz Biotechnology
sc-7345), γH2AX ser139 (Millipore-Merck 05-636 andCell Signal-
ing Technology 9718), 53BP1 (Abcam 21083 and Cell Signaling
Technology 4937), H4K16ac (Millipore-Merck 07-329), H4 (Ac-
tiveMotif 39163),H3K9ac (ActiveMotif 61252),H3 (ActiveMotif
39763), cleaved caspase 3 (Cell Signaling Technology 9661), p-38
MAPK Thr180/Tyr182 (Cell Signaling Technology 9211), p38
MAPK (Cell Signaling Technology 9212), p-S6 ser235/236 (Cell
Signaling Technology 2211), pS6 (Cell Signaling Technology
2317), IRAK1 (Santa Cruz Biotechnology 5288), Actin (Sigma-Al-
drich A1978), GAPDH (Cell Signaling Technology 5174), IL1α
(R&D Systems AF-400), and 4-HNE (JaICA).
Immunoblotting
Cells were lysed in SDS sample buffer (62.5 mM Tris at pH 6.8,
0.01% bromophenol blue, 10% glycerol, 2% SDS) or in EBC buff-
er (50 mM Tris-HCl at pH 8.0, 120 mM NaCl, 0.5% NP40). Tis-
sues were removed and homogenized in SDS sample buffer.
Proteins were separated on a 4%–12% Bis-Tris gel (NuPAGE,
Thermo Fisher Scientific) by electrophoresis and transferred to
PVDF membrane. The membranes were blocked in 4% BSA in
Tris-buffered saline (TBS) for 1 h at room temperature and then in-
cubated with the primary antibodies overnight at 4°C. Primary
antibodies were diluted in 4% BSA in TBS supplemented with
0.1% Tween 20 (TBST). Membranes were washed three times
with TBST, followed by incubation with horseradish-peroxi-
dase-conjugated secondary antibodies at room temperature for 1
h in 4% BSA/TBS. The membranes were washed again three
times. Antibody binding was visualized using a Pierce ECLWest-
ern blotting substrate (Pierce 32106).
Immunoprecipitation
Cells were lysed in EBC buffer containing 50 mM Tris-HCl pH
8.0, 120 mM NaCl, 0.5% NP40 supplemented with protease in-
hibitor cocktail (Sigma-Aldrich). The lysate was rotated for
30 min at 4°C followed by centrifugation at 13000g for 10 min
at 4°C. The supernatant was incubated with antibody-conjugated
Dynabeads (Thermo Fisher Scientific) and rotated overnight at 4°
C. The IP was washed and collected by magnet five times with
buffer containing 20 mM Tris (pH 8), 1 mM EDTA, 0.5% NP40,
and 100 mM NaCl. After washing, the IP was boiled with SDS
sample buffer. Samples were analyzed by immunoblotting.
Immunofluorescence
Cells were seeded onto coverslips and fixed in 4% paraformalde-
hyde in PBS for 15 min at room temperature. Cells were washed
twice with PBS and permeabilized with 0.2% Triton X-100 in
PBS for 5 min. After washing twice, cells were blocked in 3%
BSA in PBS supplemented with 1% goat serum for 1 h at room
temperature. Cells were then incubated with primary antibodies
in 3% BSA in PBS supplemented with 1% goat serum for 1 h at
room temperature. Next, cells were washed three times with
PBS supplementedwith 0.1%Tween 20 (PBST) for 5min each fol-
lowed by incubationwith Alexa Fluor-conjugated secondary anti-
body (Thermo Fisher Scientific) in 3% BSA in PBS supplemented
with 1% goat serum for 1 h at room temperature. The cells were
then washed three times with PBS and incubated with 1 μg/mL
DAPI for 5 min. The cells were then washed twice with PBS
and mounted with ProLong Gold (Thermo Fisher Scientific) and
imaged with a Leica or NikonA1R laser scanning confocal micro-
scope. Quantification of the percentage of positive cells for
γH2AX was done manually by using ImageJ software. Over 200
cells from 10 randomly selected fields were analyzed.
Quantitative real-time PCR
Total RNA from cells was extracted using the RNeasy Mini kit
(Qiagen), with a DNase I (Qiagen) digestion tominimize genomic
DNA contamination. Complementary DNAs were generated us-
ing SuperScript III reverse transcriptase (Thermo Fisher Scien-
tific), dNTPs, and random hexamers. Quantitative real-time
PCRwas carried out in a C1000TMThermal Cycler (Bio-Rad) us-
ing TaqManUniversal PCRMasterMix (Bio-Rad). The average of
theΔΔC(t) of triplicate sampleswas calculated usingGAPDH as a
housekeeping gene. The following TaqMan probes (Thermo Fish-
er Scientific) were used for RT-qPCR of human cells: IL1α
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(Hs00174092_m1), IL1β (Hs01555410_m1), CXCL8 (Hs01553
824_g1), IL6 (Hs00174131_m1), SOD2 (Hs00167309_m1), and
GAPDH (Hs02786624_g1). Mouse liver tissue samples were
weighed and total RNA was extracted from 30 mg using the
RNeasy Mini kit (Qiagen). Reverse transcription was performed
as previously described. Quantitative real-time PCR was carried
out in a C1000TM Thermal Cycler (Bio-Rad) using DyNAmo
SYBR Green Master Mix (Thermo Fisher Scientific). The average
of the ΔΔC(t) of triplicate samples was calculated using GAPDH
as a housekeeping gene. The following primers were used for
RT-qPCR of mouse tissues: Hmox1 (GTCAAGCACAGGGTGA
CAGA and ATCACCTGCAGCTCCTCAAA), Gsta1 (CAGCC
TGGCAGCCAGAGA and TCTGTGGCTCCATCAATGCA),
Nqo1 (TTTAGGGTCGTCTTGGCAAC and GTCTTCTCTGA
ATGGGCCAG), Srxn1 (AAAGTGCAGAGCCTGGTG and CT
TTGATCCAGAGGACGTCG), and Gapdh (AACTTTGGCATT
GTGGAAGG and ACACATTGGGGGTAGGAACA).
RNA sequencing
Total RNAwas extracted from cells or 30 mg of mouse tissue us-
ing the RNeasy minikit (Qiagen). Purified RNAwas tested on an
Agilent 2200 TapeStation using RNA screentape. mRNA-seq li-
braries were prepared using the TruSeq Stranded LT (Illumina
kit). Samples were run on the Illumina NextSeq 500 using a
High Output 75 cycle kit (twice for 36 cycles, paired-end reads,
single index). Sample datawere demultiplexed using the bcl2fastq
tool (Illumina) before read quality was assessed using the FastQC
algorithm, and then reads were trimmed appropriately using the
TrimGalore! tool (Babraham Bioinformatics). Data were then
aligned to an hg19 ormm9 reference genome (Ensembl), as appro-
priate, using the Tophat2 algorithm (Trapnell et al. 2010; Kim
et al. 2013). FPKM determination and differential expression
analysis were performed using the Cufflink and Cuffdiff tools, re-
spectively, from the Cufflinks suite. PCA analysis was performed
using custom R scripts, then plotted using the Rgl package in
R. Heat maps showing FPKM values of named gene subsets
were produced using custom R scripts, with cohort means of Z-
scores plotted.
RNA sequencing data were uploaded to GEO under accession
number GSE132371.
Nanostring
Total RNA from cells was extracted using an RNeasy minikit
(Qiagen). Purified RNA was tested on an Agilent 2200 TapeSta-
tion using RNA screentape. Samples were run on an nCounter
platform using the nCounter custom human SASP panel contain-
ing 31 canonical SASP genes (Coppé et al. 2010) and three internal
reference genes or nCounter human inflammation panel contain-
ing 249 inflammation-related genes and six internal reference
genes. Hybridization reactions were performed according the
manufacturer’s instructions (NanoString Technologies). To as-
sess data quality, the field of view counts and binding density
measurements were manually extracted from the data and veri-
fied as acceptable according to the manufacturer’s protocol. Pos-
itive control linearity and limit of detection were then verified
using customR scripts. Counts were normalized using the Nano-
StringNorm R package, using the “mean.3ds” and “geo.mean”
parameters to return high confidence values. Differential expres-
sion analysis was performed using nSolver or custom R scripts to
determine log2 fold changes and P-values (obtained using Stu-
dent’s t-test). P-values of <0.05 were considered statistically sig-
nificant. PCA analysis was performed using custom R scripts,
then plotted using the Rgl package in R. Heat maps depicting
the normalized counts of named gene subsets were produced us-
ing GraphPad Prism v8 or customR scripts, with cohortmeans of
Z-scores plotted.
Click-iT EdU incorporation assay
Cells were seeded onto coverslips and incubated with 10 μMEdU
(Thermo Fisher Scientific) in complete medium for 2 h. Cells
were then washed twice with PBS and fixed with 3.7% formalde-
hyde in PBS for 15 min at room temperature, followed by perme-
abilization with 0.5% Triton X-100 in PBS for 20 min at room
temperature. The EdU detection was performed following the in-
structions of the Click-iT imaging kit (Thermo Fisher Scientific).
Ten images per conditionwere acquiredwith a 40×magnification
objective. The number of EdU-positive cells and DAPI-positive
cells was determined using ImageJ.
Measurement of mitochondrial ROS
Mitochondrial ROS were determined by harvesting and incu-
bating∼ 5×105 live cells with 5 µM MitoSOX Red (Molecular
Probes, Thermo Fisher Scientific) in serum-free DMEM for
10 min at 37°C in the dark. Cells were centrifuged at 1200 rpm
for 2 min, the supernatant was discarded, and the cell pellet
was resuspended in PBS for flow cytometry analysis. For raw
data, see Supplemental Figures S6–S8.
Measurement of mitochondrial membrane potential
The indicated cells (5 × 105) were seeded and incubated with 100
nM tetramethylrhodamine ethyl ester (TMRE) (Thermo Fisher
Scientific) and 100 nM Mitotracker Green FM (MTG, Thermo
Fisher Scientific) in complete medium for 30 min at 37°C in the
dark. Cells were trypsinized, and the cell pellet was washed
with PBS and analyzed by flow cytometry. The ratio of TMRE
to MTG fluorescence intensity was used to represent the mito-
chondrial membrane potential per unit of mitochondrial mass.
Chromatin fragment extraction and transfection
Extraction of chromatin fragments was performed as described
previously (Dou et al. 2017). Briefly, proliferating IMR90 cells
were scraped with buffer containing 10 mM Tris (pH 7.5),
30 mM NaCl, 3 mM MgCl2, and 0.1% NP40, supplemented
with protease inhibitor cocktail (Sigma-Aldrich). Following
10 min of incubation on ice, the suspension was centrifuged at
300g for 3 min at 4°C. The supernatant was removed, and the pel-
let was incubated with benzonase buffer containing 50 mM Tris
(pH 7.5), 300 mM NaCl, 0.5% NP40, and 2.5 mM MgCl2, with
protease inhibitor cocktail (Sigma-Aldrich) supplemented with
10 U of benzonase (Sigma-Aldrich). The lysate was incubated
for 30 min on ice. The product was centrifuged at 300g for 5
min at 4°C. The supernatant was diluted twice with buffer con-
taining 50 mM Tris (pH 7.5), 300 mM NaCl, 0.5% NP40, and
15mMEDTA. Chromatin fragments were transfected to prolifer-
ating IMR90 cells using Lipofectamine 2000 (Thermo Fisher Sci-
entific). Transfected cells were harvested 4 d after transfection.
Mouse experiments
Male C57BL/6 mice (6–8 wk old) were purchased from Charles
River Laboratories. Mice were maintained under a specific path-
ogen-free environment and kept under standard conditions with
a 12-h light/dark cycle and fed ad libitum on a regular diet. All an-
imal experiments were carried out under procedural guidelines
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and severity protocols with ethical permission form the Animal
Welfare and the Ethical Review Body and Home Office (UK).
For ionizing radiation, mice were treated with 300 mg/L Vori-
nostat (SAHA) (Selleck Chemicals) or the equivalent concentra-
tion of vehicle 2-hydroxypropyl-β-cyclodextrin (HOP-β-CD)
(Sigma-Aldrich) in drinking water 1 d prior to irradiation for 8 d.
SAHA and HOP-β-CD were prepared as described previously
(Hockly et al. 2003). Briefly, 0.3 g of SAHAwas added to a solution
of 9 g of HOP-β-CD in 1 L of water and heated until fully dis-
solved. An equivalent concentration of HOP-β-CD without
SAHAwas given to the vehicle-treated mice. Mice were then ex-
posed to a sublethal dose of 4 Gy irradiation and were harvested 7
d after the procedure.
For acetaminophen (APAP) studies, 9-wk-old male C57BL/6
mice were administered 0.5 mg/kg Trichostatin A (TSA)
(Sigma-Aldrich) or vehicle 10% DMSO via intraperitoneal (i.p.)
injection 1 d prior to APAP administration. APAP was delivered
in PBS at 350 mg/kg by single i.p. injection of 20 μL/g after a
10-h fast.
Mice were sacrificed by CO2 inhalation. Liver tissue was har-
vested and fixed in formalin for histological analysis. Part of the
tissue was also frozen and stored at −80°C for biochemical
analysis.
Immunohistochemistry
After formalin fixation for 24 h, tissueswere embedded in paraffin
wax. Three-micrometer-thick sections were subjected to im-
munohistochemical staining using standard procedures at the
institutional histology core facilities. Briefly, sections were dew-
axed, dehydrated, and subjected to antigen retrieval (25-min incu-
bation at 98°C in citrate buffer at pH 6). After incubation with the
primary antibodies for 35 min at room temperature and blocking
of endogenous peroxidase (Dako) for 5 min at room temperature,
sections were incubated for 30min at room temperaturewith the
detection system (Envision system, Dako), followed by incuba-
tion with 3,3′-diaminobenzidine tetrahydrochloride (Dako) and
counterstaining with hematoxylin (Cell Path). 4-HNE staining
was performed using the Vectastain ABC system (Vector Labora-
tories) with the avidin/biotin peroxidase complex (ABC) method
and M.O.M. (mouse on mouse) immunodetection kit. Sections
were incubated in NovaRed (Vector Laboratories) solution and
counterstained in hematoxylin (Sigma Aldrich). Quantification
of positively stained hepatocytes is the mean value of four ran-
domly imaged fields per mouse.
Statistical analysis
Statistical significance was calculated by unpaired two-tailed
Student’s t-test and one-way ANOVA coupled with Dunnett’s
test as described in the figure legends. Prism 6 software
was used to generate graphs and to perform statistical analysis.
P-values of statistical significance are represented as P< 0.0001
(∗∗∗∗), P<0.001 (∗∗∗), P <0.01 (∗∗), and P <0.05 (∗). Observed/ex-
pected overlaps analysis was performed using permutation analy-
sis to simulate >1000 random overlaps of appropriate size. Gene
set enrichment analysis (http://software.broadinstitute.org/
gsea/index.jsp) was conducted using a custom gene set of
85 nuclear-encoded oxidative phosphorylation genes and was
run with default parameters using 1000 gene set permutations
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